Evaluating association between thrombocytopenia and hypertension in pregnancy and its fetomaternal outcome


  • Alisha Gupta Department of Obstetrics and Gynecology, LLRM Medical College, Meerut, Uttar Pradesh, India
  • Vandana Dhama Department of Obstetrics and Gynecology, LLRM Medical College, Meerut, Uttar Pradesh, India
  • Shakun Singh Department of Obstetrics and Gynecology, LLRM Medical College, Meerut, Uttar Pradesh, India
  • Rachna Chaudhary Department of Obstetrics and Gynecology, LLRM Medical College, Meerut, Uttar Pradesh, India




HELLP, PIH, Pregnancy induced thrombocytopenia


Background: Hypertension in pregnancy is common complication of pregnancy with incidence 5-15% and associated with maternal and perinatal mortality and morbidity. Platelet count is most simple, rapid and economical method of prediction of pregnancy induced hypertension. The aim and objective of study was to corelate with severity of thrombocytopenia and its association with fetal and maternal outcome.

Methods: This study was a case control study and was conducted in department of obsterics and gynecology, SVBP hospital attached to LLRM medical college, Meerut, from October 2020 To June 2022. Total number of 100 pregnant females out of which 50 pregnant females with hypertension as cases and 50 pregnant females without hypertension as control were included in study. Observations were tabulated, analysed and conclusions were drawn.

Results: Out of 50 cases 43 patients developed preeclampsia thus giving incidence of 43 % and out of which 21 patients had mild thrombocytopenia,13 moderate thrombocytopenia and 4 severe thrombocytopenia. The mean age amongst cases was 26.73±5.19SD and the mean age amongst control was 28.09±4.83. There was very high significant relationship between the degree of thrombocytopenia with severity of hypertension during pregnancy (at p <0.01). 24% fetuses had preterm birth, 8% had fetal growth restriction, 2% were IUD and 2% mortality. 2% of mothers had DIC,8% had post-partum hemorrhage, 6% had abruption ,4% had pulmonary edema and 6% mortality.

Conclusions: Thrombocytopenia is most common and can be life threatening complication of pregnancy induced hypertension. Therefore, platelet count can be used as an early, easy, simple, most economical and rapid test to assess severity of preeclampsia and to prevent its progression to eclampsia, HELLP syndrome and DIC.


Alkholyå EAM, Faragç EA, Beheryñ MA, Ibrahimå MM. The significance of platelet count, mean platelet volume and platelet width distribution in preeclampsia. AAMJ. 2013;11:200-14.

Habas E, Rayani A, Ganterie R. Thrombocytopenia in hypertensive disease of pregnancy. J Obst Gynecol India. 2013;63(2):96-100.

Dadhich S, Agarwal S, Soni M, Choudhary R, Jain R, Sharma S, et al. Predictive value of platelet indices in development of preeclampsia. SAFOG. 2012;4:17-21.

Han L, Liu X, Li H, Zou J, Yang Z, Han J, et al. Blood coagulation parameters and platelet indices: changes in normal and preeclamptic pregnancies and predictive values for preeclampsia. PLoS One. 2014; 9(12):e114488.

Wolde Z, Segni H, Woldie M. Hypertensive disorders of pregnancy in Jimma University specialized hospital. Ethiop J Health Sci. 2011;21:147-54.

Fadlelseed EO, Mohamedahmed KA, Mohamed AM, Hassan MI, Talha AA. Platelet parameters assessment among sudanese pregnant women with preeclampsia attending wad medani obstetrics and gynecology teaching hospital. Res Square. 2021;2:1-9.

Hussein MM, Mooij JM, Roujouleh H. Hypertension in pregnancy: Presentation, management and outcome-A Retrospective Analysis of 135 Cases. Saudi J Kidney Dis Transplant. 1998;9(4):416.

Donimath KV, Sambrani AM, Rathod PM. A study on association of thrombocytopenia with pregnancy induced hypertension. Int J Reprod Contracept Obstet Gynecol. 2016;5:808-12.

Abalos RS, Ellasus RO, Gutierrez JM. Fetomaternal outcomes of hospitalized hypertensive gravida in Shaqra General Hospital: a retrospective study. Int J Adv Nurs Studies. 2015;4(1):7.

Al-Ghamdi SM, Al-Harbi AS, Khalil A, El-Yahyia AR. Hypertensive disorders of pregnancy: Prevalence, classification and adverse outcomes in northwestern Saudi Arabia. Ann Saudi Med. 1999; 19(6):557-60.

Riaz S, Habib S, Jabeen A. Frequency of maternal mortality and morbidity in pregnancy-induced hypertension. J Ayub Med Coll Abbottabad. 2011;23: 61-3.

Rupakala BM, Gupta R, Shetty VH, Sailakshmi MPA. Thrombocytopenia in hypertensive disorders of pregnancy. Int J Reprod Contracept Obstet Gynecol. 2018;7:848-54.

Meshram DP, Chavan YH, Kadam PN, Panchal MG, Ramteke DJ. Maternal and foetal outcomes in pregnancy induced hypertension: A hospital based study. Int J Pharm Sci Invent. 2014;3:23-6.

Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102(1):181-92.

Bangal VB, Giri PA, Mahajan AS. Maternal and foetal outcome in pregnancy induced hypertension: A study from rural tertiary care teaching hospital in India. Int J Biomed Res. 2011;2(12):595-9.

Brown MA, Magee LA, Kenny LC. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24-43.

Raina N, Mehta R. Reducing neonatal mortality: a need to address pre-term births. Asia J Public Health. 2013;2:1-2

Sandhya S, Vishnu BB, Bhawana AB. Effect of pregnancy induced hypertension on mothers and their babies. Indian J Pediatr. 2007;74:623-5.






Original Research Articles